Scienture Holdings Debt to Equity Ratio 2013-2024 | SCNX
Current and historical debt to equity ratio values for Scienture Holdings (SCNX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Scienture Holdings debt/equity for the three months ending June 30, 2024 was 0.00.
| Scienture Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.00B | $0.01B | 0.26 |
| 2024-03-31 | $0.00B | $0.01B | 0.23 |
| 2023-12-31 | $0.01B | $0.00B | 22.11 |
| 2023-09-30 | $0.01B | $0.01B | 0.87 |
| 2023-06-30 | $0.01B | $-0.00B | -3.89 |
| 2023-03-31 | $0.00B | $0.00B | 5.16 |
| 2022-12-31 | $0.00B | $0.00B | 9.82 |
| 2022-09-30 | $0.00B | $0.00B | 2.46 |
| 2022-06-30 | $0.00B | $0.00B | 2.14 |
| 2022-03-31 | $0.00B | $0.00B | 1.02 |
| 2021-12-31 | $0.00B | $0.00B | 0.53 |
| 2021-09-30 | $0.00B | $0.01B | 0.19 |
| 2021-06-30 | $0.00B | $0.01B | 0.19 |
| 2021-03-31 | $0.00B | $0.01B | 0.18 |
| 2020-12-31 | $0.00B | $0.01B | 0.13 |
| 2020-09-30 | $0.00B | $0.01B | 0.10 |
| 2020-06-30 | $0.00B | $0.01B | 0.16 |
| 2020-03-31 | $0.00B | $0.01B | 0.19 |
| 2019-12-31 | $0.00B | $0.00B | 0.35 |
| 2019-09-30 | $0.00B | $0.00B | 0.51 |
| 2019-06-30 | $0.00B | $0.00B | 1.75 |
| 2019-03-31 | $0.00B | $0.00B | 1.71 |
| 2018-12-31 | $0.00B | $0.00B | 1.64 |
| 2018-09-30 | $0.00B | $0.00B | 2.78 |
| 2018-06-30 | $0.00B | $0.00B | -6.88 |
| 2018-03-31 | $0.00B | $0.00B | -4.54 |
| 2017-12-31 | $0.00B | $0.00B | -2.98 |
| 2017-09-30 | $0.00B | $0.00B | -2.07 |
| 2017-06-30 | $0.00B | $-0.00B | -1.67 |
| 2017-03-31 | $0.00B | $-0.00B | -1.71 |
| 2016-12-31 | $0.00B | $-0.00B | -1.29 |
| 2016-09-30 | $0.00B | $-0.00B | -2.00 |
| 2016-06-30 | $0.00B | $-0.00B | -2.69 |
| 2016-03-31 | $0.00B | $0.00B | -24.44 |
| 2015-12-31 | $0.00B | $0.00B | 6.59 |
| 2015-09-30 | $0.00B | $0.00B | 2.56 |
| 2015-06-30 | $0.00B | $0.00B | 2.42 |
| 2015-03-31 | $0.00B | $0.00B | 1.79 |
| 2014-12-31 | $0.00B | $0.00B | 0.83 |
| 2014-09-30 | $0.00B | $0.00B | 1.53 |
| 2014-06-30 | $0.00B | $0.00B | -5.31 |
| 2014-03-31 | $0.00B | $0.00B | 98.18 |
| 2013-12-31 | $0.00B | $0.00B | 2.09 |
| 2013-09-30 | $0.00B | $0.00B | 0.00 |
| 2013-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-03-31 | $0.00B | $0.00B | 0.00 |
| 2012-12-31 | $0.00B | $0.00B | 10.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.012B | $0.008B |
| TRxADE HEALTH INC. is a health services IT company focused on digitalizing the retail pharmacy experience. TRxADE HEALTH INC., formerly known as TRxADE Group Inc., is based in TAMPA, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $114.104B | 13.91 |
| Cencora (COR) | United States | $43.339B | 16.56 |
| DiDi Global (DIDIY) | China | $24.254B | 0.00 |
| ICON (ICLR) | Ireland | $24.216B | 21.76 |
| Avantor (AVTR) | United States | $17.207B | 26.09 |
| Natera (NTRA) | United States | $16.059B | 0.00 |
| Revvity (RVTY) | United States | $15.289B | 26.77 |
| BioMerieux (BMXMF) | France | $13.891B | 0.00 |
| Viatris (VTRS) | United States | $13.833B | 4.21 |
| CochLear (CHEOY) | Australia | $13.111B | 0.00 |
| Solventum (SOLV) | United States | $11.699B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.635B | 32.27 |
| Charles River Laboratories (CRL) | United States | $9.848B | 18.61 |
| Sonic Healthcare (SKHHY) | Australia | $8.945B | 0.00 |
| Doximity (DOCS) | United States | $8.138B | 51.56 |
| HealthEquity (HQY) | United States | $7.256B | 39.38 |
| Bausch + Lomb (BLCO) | Canada | $6.689B | 28.79 |
| PACS (PACS) | United States | $5.867B | 0.00 |
| Life Times (LTH) | United States | $4.961B | 41.47 |
| Organon (OGN) | United States | $4.709B | 4.79 |
| Sotera Health (SHC) | United States | $4.475B | 22.57 |
| Surgery Partners (SGRY) | United States | $3.961B | 43.89 |
| GoodRx Holdings (GDRX) | United States | $2.690B | 101.29 |
| Concentras Parent (CON) | United States | $2.655B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.568B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.531B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.089B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| Premier (PINC) | United States | $1.923B | 8.64 |
| CareDx (CDNA) | United States | $1.630B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.548B | 0.00 |
| Progyny (PGNY) | United States | $1.472B | 25.87 |
| AMN Healthcare Services Inc (AMN) | United States | $1.456B | 7.31 |
| GeneDx Holdings (WGS) | United States | $1.342B | 0.00 |
| Agilon Health (AGL) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| QDM (QDMI) | Hong Kong, SAR China | $1.125B | 29.47 |
| Pediatrix Medical (MD) | United States | $1.042B | 11.34 |
| Embecta (EMBC) | United States | $0.780B | 5.20 |
| InnovAge Holding (INNV) | United States | $0.746B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.529B | 0.00 |
| Sharecare (SHCR) | United States | $0.528B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.425B | 0.00 |
| Enhabit (EHAB) | United States | $0.376B | 32.52 |
| DocGo (DCGO) | United States | $0.343B | 12.88 |
| Biodesix (BDSX) | United States | $0.245B | 0.00 |
| ModivCare (MODV) | United States | $0.241B | 7.67 |
| Sera Prognostics (SERA) | United States | $0.241B | 0.00 |
| LifeMD (LFMD) | United States | $0.208B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.174B | 0.00 |
| MultiPlan (MPLN) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.125B | 30.25 |
| Nutex Health (NUTX) | United States | $0.111B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 1.72 |
| SBC Medicals (SBC) | United States | $0.042B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |